/Investor DB

Excelerate Health Ventures — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

OrbitalRxorbitalrx.comin𝕏Oct 2025

Orbital RX provides a software platform for hospital pharmacy supply chain management that integrates inventory tracking, procurement workflows, and real-time team collaboration to coordinate shortage response across healthcare networks.

AI & Machine LearningEnterprise SoftwareHealthtechSaaS

Nate Peaty(Founder)in

Board seatGary Abrahams· per SEC Form D

Co-investorsAlerion VenturesThe Launch PlaceHatteras Venture Partners

Bekhealthbekhealth.cominFeb 2025

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.

AI & Machine LearningDigital HealthHealthtechBranford, US

Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in

Co-investorsConnecticut InnovationsHatteras Venture PartnersMartin VenturesBoston Millennia PartnersSopris Venture Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Geno.Me, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.